ID: ALA5270593

Max Phase: Preclinical

Molecular Formula: C24H26O5S

Molecular Weight: 426.53

Associated Items:

Representations

Canonical SMILES:  O=C(O)CCCCC1(c2ccccc2)CC(O)=C(SCCc2ccccc2)C(=O)O1

Standard InChI:  InChI=1S/C24H26O5S/c25-20-17-24(15-8-7-13-21(26)27,19-11-5-2-6-12-19)29-23(28)22(20)30-16-14-18-9-3-1-4-10-18/h1-6,9-12,25H,7-8,13-17H2,(H,26,27)

Standard InChI Key:  FMMHYWMOZXVKBQ-UHFFFAOYSA-N

Associated Targets(non-human)

Human immunodeficiency virus type 1 protease 9113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 426.53Molecular Weight (Monoisotopic): 426.1501AlogP: 5.22#Rotatable Bonds: 10
Polar Surface Area: 83.83Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.02CX Basic pKa: CX LogP: 4.82CX LogD: -0.87
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.40Np Likeness Score: 0.30

References

1. Hassan MZ, Osman H, Ali MA, Ahsan MJ..  (2016)  Therapeutic potential of coumarins as antiviral agents.,  123  [PMID:27484512] [10.1016/j.ejmech.2016.07.056]

Source